Formation of P450 · P450 complexes and their effect on P450 function

Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzy...

Full description

Saved in:
Bibliographic Details
Published inPharmacology & therapeutics (Oxford) Vol. 133; no. 3; pp. 299 - 310
Main Authors Reed, James R, Backes, Wayne L
Format Journal Article
LanguageEnglish
Published England 01.03.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzymes do not act alone but require an interaction with other electron transfer proteins such as NADPH-cytochrome P450 reductase (CPR) and cytochrome b(5). Because P450s are localized in the endoplasmic reticulum with these and other ER-resident proteins, there is a potential for protein-protein interactions to influence P450 function. There has been increasing evidence that P450 enzymes form complexes in the ER, with compelling support that formation of P450 · P450 complexes can significantly influence their function. Our goal is to review the research supporting the formation of P450 · P450 complexes, their specificity, and how drug metabolism may be affected. This review describes the potential mechanisms by which P450s may interact, and provides evidence to support each of the possible mechanisms. Additionally, evidence for the formation of both heteromeric and homomeric P450 complexes are reviewed. Finally, direct physical evidence for P450 complex formation in solution and in membranes is summarized, and questions directing the future research of functional P450 interactions are discussed with respect to their potential impact on drug metabolism.
AbstractList Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzymes do not act alone but require an interaction with other electron transfer proteins such as NADPH-cytochrome P450 reductase (CPR) and cytochrome b 5 . Because P450s are localized in the endoplasmic reticulum with these and other ER-resident proteins, there is a potential for protein-protein interactions to influence P450 function. There has been increasing evidence that P450 enzymes form complexes in the ER, with compelling support that formation of P450•P450 complexes can significantly influence their function. Our goal is to review the research supporting the formation of P450•P450 complexes, their specificity, and how drug metabolism may be affected. This review describes the potential mechanisms by which P450s may interact, and provides evidence to support each of the possible mechanisms. Additionally, evidence for the formation of both heteromeric and homomeric P450 complexes are reviewed. Finally, direct physical evidence for P450 complex formation in solution and in membranes is summarized, and questions directing the future research of functional P450 interactions are discussed with respect to their potential impact on drug metabolism.
Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzymes do not act alone but require an interaction with other electron transfer proteins such as NADPH-cytochrome P450 reductase (CPR) and cytochrome b(5). Because P450s are localized in the endoplasmic reticulum with these and other ER-resident proteins, there is a potential for protein-protein interactions to influence P450 function. There has been increasing evidence that P450 enzymes form complexes in the ER, with compelling support that formation of P450 · P450 complexes can significantly influence their function. Our goal is to review the research supporting the formation of P450 · P450 complexes, their specificity, and how drug metabolism may be affected. This review describes the potential mechanisms by which P450s may interact, and provides evidence to support each of the possible mechanisms. Additionally, evidence for the formation of both heteromeric and homomeric P450 complexes are reviewed. Finally, direct physical evidence for P450 complex formation in solution and in membranes is summarized, and questions directing the future research of functional P450 interactions are discussed with respect to their potential impact on drug metabolism.
Author Reed, James R
Backes, Wayne L
Author_xml – sequence: 1
  givenname: James R
  surname: Reed
  fullname: Reed, James R
  organization: Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
– sequence: 2
  givenname: Wayne L
  surname: Backes
  fullname: Backes, Wayne L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22155419$$D View this record in MEDLINE/PubMed
BookMark eNpVkN1KwzAYhoNM3I_eguQGWr-kadOeCDI2FQZ6oOBZSPPjOtampJ3olXnulZk6nQofvAff-wPPFI0a1xiEMIGYAMkuNnG7lr7u18bLmAIhcTiA4ghNSM6LKHieRmgSJIk4TfMxmnbdBgAYA3qCxpSSNGWkmKDF0vla9pVrsLP4nqWAP973qlzdbs2r6bBsNA5blcfGWqN6HNxfFrtr1JA9RcdWbjtz9q0z9LhcPMxvotXd9e38ahWpMNZHKuUZlTkrM52bHBhoqTkvCKHMcLDclFwnOmG6UNRmpZU2Y0xbSTNSgi1NMkOX-952V9ZGK9P0Xm5F66ta-jfhZCX-f5pqLZ7di0gop4SwUJDvC5R3XeeNPWQJiAGt2IhftGJAK8IFtCF6_nf7EPxhmXwCpsJ7YA
CitedBy_id crossref_primary_10_1042_BCJ20170543
crossref_primary_10_1021_acs_biochem_7b01012
crossref_primary_10_1016_j_ymgme_2019_01_015
crossref_primary_10_1042_BJ20120636
crossref_primary_10_1074_jbc_M114_615443
crossref_primary_10_1016_j_abb_2020_108677
crossref_primary_10_1016_j_taap_2015_09_021
crossref_primary_10_1002_pro_3603
crossref_primary_10_3389_fphar_2023_1055991
crossref_primary_10_1124_dmd_121_000758
crossref_primary_10_1016_j_phytol_2021_10_006
crossref_primary_10_1080_07391102_2021_1925154
crossref_primary_10_1007_s40610_017_0053_y
crossref_primary_10_1371_journal_pone_0202534
crossref_primary_10_3390_molecules27206870
crossref_primary_10_1016_j_tips_2021_09_004
crossref_primary_10_1016_j_pharmthera_2019_107414
crossref_primary_10_1124_dmd_114_057901
crossref_primary_10_1016_j_jinorgbio_2018_03_002
crossref_primary_10_3389_fphar_2024_1397288
crossref_primary_10_1097_MNM_0000000000000875
crossref_primary_10_1080_03602532_2016_1221961
crossref_primary_10_1016_j_cellsig_2020_109769
crossref_primary_10_1074_jbc_RA120_015911
crossref_primary_10_3390_ijms141224438
crossref_primary_10_1016_S1452_3981_23_14007_7
crossref_primary_10_1124_dmd_115_068569
crossref_primary_10_1124_dmd_115_067637
crossref_primary_10_18097_PBMC20156102176
crossref_primary_10_1124_dmd_112_046094
crossref_primary_10_1042_BJ20130398
crossref_primary_10_1021_acs_jpcb_6b10108
crossref_primary_10_1007_s11095_018_2548_5
crossref_primary_10_1021_tx500203s
crossref_primary_10_1042_BJ20140787
crossref_primary_10_1016_j_bbapap_2017_06_007
crossref_primary_10_1021_acs_molpharmaceut_6b00920
crossref_primary_10_1042_BCJ20210269
crossref_primary_10_1016_j_bioelechem_2016_05_005
crossref_primary_10_1042_BCJ20190532
crossref_primary_10_1080_03602532_2020_1765792
crossref_primary_10_3390_ijms231911458
crossref_primary_10_1021_jacs_7b00663
crossref_primary_10_1042_BSR20171161
crossref_primary_10_1124_mol_115_098582
crossref_primary_10_1002_cbin_11564
crossref_primary_10_3389_fphar_2017_00028
crossref_primary_10_1124_dmd_115_068593
crossref_primary_10_1002_prp2_53
crossref_primary_10_1016_j_jinorgbio_2023_112325
crossref_primary_10_1016_j_abb_2021_108937
crossref_primary_10_1016_j_tplants_2014_11_002
crossref_primary_10_1016_j_tiv_2019_01_002
crossref_primary_10_1038_s41598_018_30195_1
crossref_primary_10_1073_pnas_1323369111
crossref_primary_10_1134_S0006350913030172
crossref_primary_10_1134_S1990750816010042
crossref_primary_10_1021_bi400422a
crossref_primary_10_1093_gigascience_giab016
crossref_primary_10_1016_j_nucmedbio_2014_08_015
crossref_primary_10_1021_jacs_7b08750
crossref_primary_10_1038_srep17671
crossref_primary_10_1016_j_taap_2014_03_021
crossref_primary_10_1124_dmd_113_054627
crossref_primary_10_1111_febs_14129
crossref_primary_10_1155_2017_8210734
crossref_primary_10_1124_dmd_115_068981
crossref_primary_10_1021_acssynbio_2c00132
Cites_doi 10.1016/0014-5793(80)80400-5
10.1124/dmd.107.018473
10.3109/00498258209038946
10.1006/abbi.1996.9859
10.1016/S0021-9258(17)35233-X
10.1016/S0021-9258(18)32132-X
10.1016/S0021-9258(19)73803-4
10.1016/S0300-9084(97)82528-X
10.1016/0304-4157(75)90006-4
10.1006/abbi.1995.1253
10.1016/j.bbabio.2009.12.008
10.1006/abbi.1996.0086
10.1016/S0021-9258(18)83427-5
10.1021/bi9514572
10.1021/bi00094a009
10.1016/0014-5793(86)80861-4
10.1016/S0021-9258(18)83341-5
10.1021/jm060706p
10.1016/0014-5793(93)81083-C
10.1006/bbrc.1995.2854
10.1016/0003-9861(72)90448-1
10.1124/dmd.110.034942
10.1124/dmd.109.026500
10.1021/bi7003476
10.1016/S0021-9258(18)34532-0
10.1016/0003-9861(82)90217-X
10.1021/bi061803n
10.2174/187231211794455253
10.1021/bi00032a003
10.1111/j.1432-1033.1985.tb09001.x
10.1086/429417
10.1016/0014-5793(90)81261-L
10.1146/annurev.bi.49.070180.001531
10.1016/0003-9861(87)90291-8
10.1016/0006-2952(86)90759-8
10.1006/abbi.1997.0125
10.1016/S0021-9258(18)34533-2
10.1006/abbi.2001.2574
10.1016/S0021-9258(17)43364-3
10.1006/abbi.1997.9995
10.1074/jbc.M109.076885
10.1007/978-1-4615-0667-6_53
10.1124/dmd.104.001578
10.1016/0003-9861(83)90045-0
10.1021/bi00175a017
10.1016/0006-291X(90)91373-Z
10.1124/dmd.105.006825
10.1073/pnas.1106632108
10.1021/bi00004a018
10.1073/pnas.90.7.2651
10.1074/jbc.275.4.2545
10.1016/S0021-9258(18)62872-8
10.1074/jbc.M301489200
10.1016/S0021-9258(19)56992-7
10.1016/0003-9861(79)90383-7
10.1016/0026-0495(71)90091-6
10.1021/bi00591a029
10.1021/bi980674a
10.1124/dmd.105.005538
10.1124/dmd.109.030155
10.1002/jbt.10052
10.1074/jbc.271.44.27438
10.1074/jbc.270.10.5014
10.1016/S0021-9258(19)85640-5
10.1016/j.abb.2004.12.008
10.1021/bi0477900
10.1021/bi00551a041
10.1021/bi0509346
10.1038/ng1300
10.1016/S0163-7258(02)00327-3
10.1016/0005-2736(80)90188-1
10.1016/0014-5793(90)81479-8
10.1016/S0021-9258(17)33349-5
10.1016/0006-291X(92)92372-5
ContentType Journal Article
Copyright Copyright © 2011 Elsevier Inc. All rights reserved.
2011 Elsevier Inc. All rights reserved. 2011
Copyright_xml – notice: Copyright © 2011 Elsevier Inc. All rights reserved.
– notice: 2011 Elsevier Inc. All rights reserved. 2011
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.1016/j.pharmthera.2011.11.009
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1879-016X
EndPage 310
ExternalDocumentID 10_1016_j_pharmthera_2011_11_009
22155419
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIEHS NIH HHS
  grantid: P42 ES013648
– fundername: NIEHS NIH HHS
  grantid: P42 ES013648-01A2
– fundername: NIEHS NIH HHS
  grantid: R01 ES004344-16A1
– fundername: NIEHS NIH HHS
  grantid: R01 ES004344
– fundername: NIEHS NIH HHS
  grantid: R01 ES004344-18
– fundername: NIEHS NIH HHS
  grantid: P42 ES013648-02
– fundername: NIEHS NIH HHS
  grantid: R01 ES004344-17
– fundername: National Institute of Environmental Health Sciences : NIEHS
  grantid: P42 ES013648-02 || ES
– fundername: National Institute of Environmental Health Sciences : NIEHS
  grantid: R01 ES004344-18 || ES
– fundername: National Institute of Environmental Health Sciences : NIEHS
  grantid: P42 ES013648-01A2 || ES
– fundername: National Institute of Environmental Health Sciences : NIEHS
  grantid: R01 ES004344-16A1 || ES
– fundername: National Institute of Environmental Health Sciences : NIEHS
  grantid: R01 ES004344-17 || ES
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
123
1B1
1RT
1~.
1~5
29O
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
ABFNM
ABMAC
ABXDB
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AFFNX
AFJKZ
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CGR
CS3
CUY
CVF
DU5
EBS
ECM
EFJIC
EIF
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M34
M41
MO0
N9A
NPM
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
TEORI
WUQ
Y6R
ZGI
ZXP
~G-
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c419t-c5762a84b6d8e8040dad7791124e70f7eb7d3d34d9c2f6bfaf644dfa261b0fbe3
ISSN 0163-7258
IngestDate Tue Sep 17 20:49:38 EDT 2024
Thu Sep 26 18:20:47 EDT 2024
Sat Sep 28 08:01:45 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Copyright © 2011 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c419t-c5762a84b6d8e8040dad7791124e70f7eb7d3d34d9c2f6bfaf644dfa261b0fbe3
OpenAccessLink https://europepmc.org/articles/pmc3272114?pdf=render
PMID 22155419
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3272114
crossref_primary_10_1016_j_pharmthera_2011_11_009
pubmed_primary_22155419
PublicationCentury 2000
PublicationDate 2012-03-01
PublicationDateYYYYMMDD 2012-03-01
PublicationDate_xml – month: 03
  year: 2012
  text: 2012-03-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pharmacology & therapeutics (Oxford)
PublicationTitleAlternate Pharmacol Ther
PublicationYear 2012
References 1985961 - J Biol Chem. 1991 Jan 15;266(2):735-9
8218220 - Biochemistry. 1993 Nov 2;32(43):11530-8
4395592 - Metabolism. 1971 Feb;20(2):187-99
117825 - Biochemistry. 1979 Nov 27;18(24):5442-9
2495281 - J Biol Chem. 1989 Apr 15;264(11):6252-9
11717170 - Drug Metab Dispos. 2001 Dec;29(12):1529-34
4385007 - J Biol Chem. 1968 Mar 25;243(6):1331-2
19448135 - Drug Metab Dispos. 2009 Aug;37(8):1682-9
6769473 - Biochemistry. 1980 May 13;19(10):2260-4
6863312 - J Biol Chem. 1983 Jul 25;258(14):8839-47
9056240 - Arch Biochem Biophys. 1997 Mar 1;339(1):107-14
20215413 - Drug Metab Dispos. 2010 Jun;38(6):1003-9
7215544 - FEBS Lett. 1980 Dec 15;122(1):54-8
4650614 - Arch Biochem Biophys. 1972 Nov;153(1):298-303
6285833 - Arch Biochem Biophys. 1982 Jun;216(1):322-8
2168169 - Biochem Biophys Res Commun. 1990 Aug 31;171(1):175-81
14486217 - J Biol Chem. 1962 Aug;237:2652-60
15486075 - Drug Metab Dispos. 2005 Jan;33(1):157-64
17311370 - J Med Chem. 2007 Mar 22;50(6):1158-65
20071338 - J Biol Chem. 2010 Mar 19;285(12):8942-52
8319808 - FEBS Lett. 1993 Jul 5;325(3):251-4
12481306 - J Biochem Mol Toxicol. 2002;16(6):311-6
6421810 - J Biol Chem. 1984 Feb 25;259(4):2390-5
6806262 - J Biol Chem. 1982 Jun 25;257(12):7030-6
8634277 - Biochemistry. 1996 Feb 6;35(5):1466-74
7085615 - J Biol Chem. 1982 Jun 25;257(12):7023-9
7890608 - J Biol Chem. 1995 Mar 10;270(10):5014-8
3592665 - Arch Biochem Biophys. 1987 May 15;255(1):27-41
15980100 - Drug Metab Dispos. 2005 Sep;33(9):1382-90
17176103 - Biochemistry. 2006 Dec 26;45(51):15807-16
16229479 - Biochemistry. 2005 Oct 25;44(42):13902-13
16415125 - Drug Metab Dispos. 2006 Apr;34(4):660-6
9185616 - Arch Biochem Biophys. 1997 Jun 1;342(1):82-91
1417844 - Biochem Biophys Res Commun. 1992 Oct 15;188(1):216-21
15793702 - Am J Hum Genet. 2005 May;76(5):729-49
3743769 - FEBS Lett. 1986 Sep 1;205(1):35-40
17685587 - Biochemistry. 2007 Sep 4;46(35):10192-201
20699412 - Drug Metab Dispos. 2010 Nov;38(11):1976-83
7168192 - Xenobiotica. 1982 Nov;12(11):717-26
6311109 - Arch Biochem Biophys. 1983 Aug;225(1):398-404
1699791 - FEBS Lett. 1990 Sep 17;270(1-2):177-80
4018075 - Eur J Biochem. 1985 Jul 1;150(1):155-9
7733676 - Arch Biochem Biophys. 1995 Apr 20;318(2):446-56
18048487 - Drug Metab Dispos. 2008 Mar;36(3):582-8
7640265 - Biochemistry. 1995 Aug 15;34(32):10113-9
12559387 - Pharmacol Ther. 2003 Feb;97(2):139-52
112928 - Arch Biochem Biophys. 1979 Jul;195(2):565-77
10644712 - J Biol Chem. 2000 Jan 28;275(4):2545-53
8464872 - Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2651-5
6996566 - Annu Rev Biochem. 1980;49:315-56
9737863 - Biochemistry. 1998 Sep 15;37(37):12852-9
20026040 - Biochim Biophys Acta. 2010 Mar;1797(3):378-90
8117709 - Biochemistry. 1994 Mar 8;33(9):2484-9
9186495 - Arch Biochem Biophys. 1997 Jun 15;342(2):329-37
8910324 - J Biol Chem. 1996 Nov 1;271(44):27438-44
20942796 - Drug Metab Lett. 2011 Jan;5(1):6-16
11764964 - Adv Exp Med Biol. 2001;500:335-8
3790162 - Biochem Pharmacol. 1986 Dec 15;35(24):4431-6
2164629 - Mol Pharmacol. 1990 Jul;38(1):134-42
819436 - J Biol Chem. 1976 Jul 10;251(13):4010-6
6773567 - Biochim Biophys Acta. 1980 Jul;599(2):417-35
2261995 - FEBS Lett. 1990 Nov 26;275(1-2):235-8
15709776 - Biochemistry. 2005 Feb 22;44(7):2632-41
4393962 - J Biol Chem. 1970 Sep 25;245(18):4851-4
12766165 - J Biol Chem. 2003 Aug 15;278(33):31269-76
6768748 - J Biol Chem. 1980 May 10;255(9):4112-9
9010599 - Biochimie. 1996;78(8-9):706-13
173395 - Biochim Biophys Acta. 1975 Dec 29;415(4):411-72
4389465 - J Biol Chem. 1969 Jul 10;244(13):3714-21
8615680 - Arch Biochem Biophys. 1996 Mar 1;327(1):11-9
15680923 - Arch Biochem Biophys. 2005 Mar 1;435(1):207-16
7827074 - Biochemistry. 1995 Jan 31;34(4):1244-7
21808038 - Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13486-91
14758361 - Nat Genet. 2004 Mar;36(3):228-30
11673866 - Arch Biochem Biophys. 2001 Nov 1;395(1):57-68
8554612 - Biochem Biophys Res Commun. 1995 Dec 26;217(3):886-91
Lu (10.1016/j.pharmthera.2011.11.009_bb0190) 1968; 243
White (10.1016/j.pharmthera.2011.11.009_bb0355) 1980; 49
Yamazaki (10.1016/j.pharmthera.2011.11.009_bb0375) 1997; 342
Koley (10.1016/j.pharmthera.2011.11.009_bb0170) 1996; 78
French (10.1016/j.pharmthera.2011.11.009_bb0090) 1979; 195
Wagner (10.1016/j.pharmthera.2011.11.009_bb0345) 1984; 259
Pernecky (10.1016/j.pharmthera.2011.11.009_bb0235) 1995; 318
Yamada (10.1016/j.pharmthera.2011.11.009_bb0370) 1995; 34
Locuson (10.1016/j.pharmthera.2011.11.009_bb0180) 2007; 50
Peterson (10.1016/j.pharmthera.2011.11.009_bb0240) 1976; 251
Dong (10.1016/j.pharmthera.2011.11.009_bb0075) 1996; 327
Kelley (10.1016/j.pharmthera.2011.11.009_bb0155) 2006; 45
Wood (10.1016/j.pharmthera.2011.11.009_bb0360) 1983; 258
Subramanian (10.1016/j.pharmthera.2011.11.009_bb0315) 2010; 38
Causey (10.1016/j.pharmthera.2011.11.009_bb0025) 1990; 38
McIntosh (10.1016/j.pharmthera.2011.11.009_bb0200) 1980; 122
Davydov (10.1016/j.pharmthera.2011.11.009_bb0065) 2010; 1797
von Wachenfeldt (10.1016/j.pharmthera.2011.11.009_bb0340) 1997; 339
Xia (10.1016/j.pharmthera.2011.11.009_bb0365) 2011; 108
Gibson (10.1016/j.pharmthera.2011.11.009_bb0100) 1986; 35
Davydov (10.1016/j.pharmthera.2011.11.009_bb0055) 1992; 188
Myasoedova (10.1016/j.pharmthera.2011.11.009_bb0220) 1993; 325
Reed (10.1016/j.pharmthera.2011.11.009_bb0260) 2011; 5
Estabrook (10.1016/j.pharmthera.2011.11.009_bb0080) 1971; 20
Loida (10.1016/j.pharmthera.2011.11.009_bb0185) 1993; 32
Viner (10.1016/j.pharmthera.2011.11.009_bb0335) 1995; 217
Ozalp (10.1016/j.pharmthera.2011.11.009_bb0225) 2005; 33
Szczesna-Skorupa (10.1016/j.pharmthera.2011.11.009_bb0320) 2003; 278
Schwarz (10.1016/j.pharmthera.2011.11.009_bb0285) 1982; 216
Koley (10.1016/j.pharmthera.2011.11.009_bb0175) 1994; 33
Cosme (10.1016/j.pharmthera.2011.11.009_bb0040) 2000; 275
Cawley (10.1016/j.pharmthera.2011.11.009_bb0030) 1995; 34
Myasoedova (10.1016/j.pharmthera.2011.11.009_bb0215) 1990; 270
Shimada (10.1016/j.pharmthera.2011.11.009_bb0295) 2005; 435
Baskin (10.1016/j.pharmthera.2011.11.009_bb0020) 1980; 19
Reed (10.1016/j.pharmthera.2011.11.009_bb0265) 2010; 285
Scott (10.1016/j.pharmthera.2011.11.009_bb0290) 2001; 395
Phillips (10.1016/j.pharmthera.2011.11.009_bb0245) 1962; 237
Cawley (10.1016/j.pharmthera.2011.11.009_bb0035) 2001; 29
Subramanian (10.1016/j.pharmthera.2011.11.009_bb0310) 2009; 37
Reed (10.1016/j.pharmthera.2011.11.009_bb0270) 2006; 34
Gut (10.1016/j.pharmthera.2011.11.009_bb0115) 1982; 257
Kawato (10.1016/j.pharmthera.2011.11.009_bb0150) 1982; 257
Davydov (10.1016/j.pharmthera.2011.11.009_bb0045) 2005; 44
West (10.1016/j.pharmthera.2011.11.009_bb0350) 1972; 153
Depierre (10.1016/j.pharmthera.2011.11.009_bb0070) 1975; 415
Jamakhandi (10.1016/j.pharmthera.2011.11.009_bb0140) 2007; 46
Pernecky (10.1016/j.pharmthera.2011.11.009_bb0230) 1993; 90
Guengerich (10.1016/j.pharmthera.2011.11.009_bb0110) 1979; 18
Sonderfan (10.1016/j.pharmthera.2011.11.009_bb0300) 1987; 255
Flück (10.1016/j.pharmthera.2011.11.009_bb0085) 2004; 36
Schwarz (10.1016/j.pharmthera.2011.11.009_bb0280) 1990; 171
Hu (10.1016/j.pharmthera.2011.11.009_bb0125) 2010; 38
Davydov (10.1016/j.pharmthera.2011.11.009_bb0060) 2001; 500
Huang (10.1016/j.pharmthera.2011.11.009_bb0130) 2005; 76
Strobel (10.1016/j.pharmthera.2011.11.009_bb0305) 1970; 245
Tan (10.1016/j.pharmthera.2011.11.009_bb0325) 1997; 342
Davydov (10.1016/j.pharmthera.2011.11.009_bb0050) 1985; 150
Kelley (10.1016/j.pharmthera.2011.11.009_bb0160) 2005; 44
Backes (10.1016/j.pharmthera.2011.11.009_bb0015) 1989; 264
Greinert (10.1016/j.pharmthera.2011.11.009_bb0105) 1982; 12
Miller (10.1016/j.pharmthera.2011.11.009_bb0205) 1996; 35
Porter (10.1016/j.pharmthera.2011.11.009_bb0250) 2002; 16
Reed (10.1016/j.pharmthera.2011.11.009_bb0255) 2008; 36
Ingelman-Sundberg (10.1016/j.pharmthera.2011.11.009_bb0135) 1980; 599
Tsuprun (10.1016/j.pharmthera.2011.11.009_bb0330) 1986; 205
Kaminsky (10.1016/j.pharmthera.2011.11.009_bb0145) 1983; 225
Koley (10.1016/j.pharmthera.2011.11.009_bb0165) 1995; 270
Alston (10.1016/j.pharmthera.2011.11.009_bb0005) 1991; 266
Backes (10.1016/j.pharmthera.2011.11.009_bb0010) 1998; 37
Lu (10.1016/j.pharmthera.2011.11.009_bb0195) 1969; 244
Myasoedova (10.1016/j.pharmthera.2011.11.009_bb0210) 1990; 275
Yamazaki (10.1016/j.pharmthera.2011.11.009_bb0380) 1996; 271
French (10.1016/j.pharmthera.2011.11.009_bb0095) 1980; 255
Hazai (10.1016/j.pharmthera.2011.11.009_bb0120) 2005; 33
Schenkman (10.1016/j.pharmthera.2011.11.009_bb0275) 2003; 97
References_xml – volume: 122
  start-page: 54
  year: 1980
  ident: 10.1016/j.pharmthera.2011.11.009_bb0200
  article-title: Evidence from cross-linking and rotational diffusion studies that cytochrome P450 can from molecular aggregates in rabbit-liver microsomal membranes
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(80)80400-5
  contributor:
    fullname: McIntosh
– volume: 36
  start-page: 582
  year: 2008
  ident: 10.1016/j.pharmthera.2011.11.009_bb0255
  article-title: Physical incorporation of NADPH–cytochrome P450 reductase and cytochrome P450 into phospholipid vesicles using glycocholate and Bio-Beads
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.107.018473
  contributor:
    fullname: Reed
– volume: 12
  start-page: 717
  year: 1982
  ident: 10.1016/j.pharmthera.2011.11.009_bb0105
  article-title: Cytochrome P-450 rotamers control mixed-function oxygenation in reconstituted membranes. Rotational diffusion studied by delayed fluorescence depolarization
  publication-title: Xenobiotica
  doi: 10.3109/00498258209038946
  contributor:
    fullname: Greinert
– volume: 339
  start-page: 107
  year: 1997
  ident: 10.1016/j.pharmthera.2011.11.009_bb0340
  article-title: Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modification of its N-terminus
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.1996.9859
  contributor:
    fullname: von Wachenfeldt
– volume: 266
  start-page: 735
  year: 1991
  ident: 10.1016/j.pharmthera.2011.11.009_bb0005
  article-title: Interactions among cytochromes P-450 in the endoplasmic reticulum. Detection of chemically cross-linked complexes with monoclonal antibodies
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)35233-X
  contributor:
    fullname: Alston
– volume: 258
  start-page: 8839
  year: 1983
  ident: 10.1016/j.pharmthera.2011.11.009_bb0360
  article-title: Regio- and stereoselective metabolism of two C19-steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)32132-X
  contributor:
    fullname: Wood
– volume: 237
  start-page: 2652
  year: 1962
  ident: 10.1016/j.pharmthera.2011.11.009_bb0245
  article-title: Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)73803-4
  contributor:
    fullname: Phillips
– volume: 78
  start-page: 706
  year: 1996
  ident: 10.1016/j.pharmthera.2011.11.009_bb0170
  article-title: Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics
  publication-title: Biochimie
  doi: 10.1016/S0300-9084(97)82528-X
  contributor:
    fullname: Koley
– volume: 415
  start-page: 411
  year: 1975
  ident: 10.1016/j.pharmthera.2011.11.009_bb0070
  article-title: Structural aspects of the membrane of the endoplasmic reticulum
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0304-4157(75)90006-4
  contributor:
    fullname: Depierre
– volume: 318
  start-page: 446
  year: 1995
  ident: 10.1016/j.pharmthera.2011.11.009_bb0235
  article-title: Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.1995.1253
  contributor:
    fullname: Pernecky
– volume: 1797
  start-page: 378
  year: 2010
  ident: 10.1016/j.pharmthera.2011.11.009_bb0065
  article-title: Electron transfer in the complex of membrane-bound human cytochrome P450 3A4 with the flavin domain of P450BM-3: the effect of oligomerization of the heme protein and intermittent modulation of the spin equilibrium
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbabio.2009.12.008
  contributor:
    fullname: Davydov
– volume: 327
  start-page: 11
  year: 1996
  ident: 10.1016/j.pharmthera.2011.11.009_bb0075
  article-title: Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH–cytochrome P450 reductase
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.1996.0086
  contributor:
    fullname: Dong
– volume: 244
  start-page: 3714
  year: 1969
  ident: 10.1016/j.pharmthera.2011.11.009_bb0195
  article-title: Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)83427-5
  contributor:
    fullname: Lu
– volume: 35
  start-page: 1466
  year: 1996
  ident: 10.1016/j.pharmthera.2011.11.009_bb0205
  article-title: X-ray diffraction analysis of cytochrome P450 2B4 reconstituted into liposomes
  publication-title: Biochemistry
  doi: 10.1021/bi9514572
  contributor:
    fullname: Miller
– volume: 32
  start-page: 11530
  year: 1993
  ident: 10.1016/j.pharmthera.2011.11.009_bb0185
  article-title: Molecular recognition in cytochrome P-450: mechanism for the control of uncoupling reactions
  publication-title: Biochemistry
  doi: 10.1021/bi00094a009
  contributor:
    fullname: Loida
– volume: 205
  start-page: 35
  year: 1986
  ident: 10.1016/j.pharmthera.2011.11.009_bb0330
  article-title: Quaternary structure of the liver microsomal cytochrome P-450
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(86)80861-4
  contributor:
    fullname: Tsuprun
– volume: 264
  start-page: 6252
  year: 1989
  ident: 10.1016/j.pharmthera.2011.11.009_bb0015
  article-title: Cytochrome P-450 LM2 reduction. Substrate effects on the rate of reductase–LM2 association
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)83341-5
  contributor:
    fullname: Backes
– volume: 50
  start-page: 1158
  year: 2007
  ident: 10.1016/j.pharmthera.2011.11.009_bb0180
  article-title: Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9
  publication-title: J Med Chem
  doi: 10.1021/jm060706p
  contributor:
    fullname: Locuson
– volume: 325
  start-page: 251
  year: 1993
  ident: 10.1016/j.pharmthera.2011.11.009_bb0220
  article-title: Cytochrome P-450: hexameric structure of the purified LM4 form
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(93)81083-C
  contributor:
    fullname: Myasoedova
– volume: 217
  start-page: 886
  year: 1995
  ident: 10.1016/j.pharmthera.2011.11.009_bb0335
  article-title: Effect of different solubilizing agents on the aggregation state and catalytic activity of two purified rabbit cytochrome p450 isozymes, CYP1A2(LM4) and CYP2B4(LM2)
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1995.2854
  contributor:
    fullname: Viner
– volume: 153
  start-page: 298
  year: 1972
  ident: 10.1016/j.pharmthera.2011.11.009_bb0350
  article-title: Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. V. Competition between cytochromes P-450 and P-448 for reductase in 3,4-benzpyrene hydroxylation
  publication-title: Arch Biochem Biophys
  doi: 10.1016/0003-9861(72)90448-1
  contributor:
    fullname: West
– volume: 38
  start-page: 1976
  year: 2010
  ident: 10.1016/j.pharmthera.2011.11.009_bb0125
  article-title: CYP2C8 exists as a dimer in natural membranes
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.110.034942
  contributor:
    fullname: Hu
– volume: 37
  start-page: 1682
  year: 2009
  ident: 10.1016/j.pharmthera.2011.11.009_bb0310
  article-title: CYP2D6–CYP2C9 protein–protein interactions and isoform-selective effects on substrate binding and catalysis
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.109.026500
  contributor:
    fullname: Subramanian
– volume: 46
  start-page: 10192
  year: 2007
  ident: 10.1016/j.pharmthera.2011.11.009_bb0140
  article-title: Global analysis of protein–protein interactions reveals multiple CYP2E1-reductase complexes
  publication-title: Biochemistry
  doi: 10.1021/bi7003476
  contributor:
    fullname: Jamakhandi
– volume: 257
  start-page: 7023
  year: 1982
  ident: 10.1016/j.pharmthera.2011.11.009_bb0150
  article-title: Rotation of cytochrome P-450. I. Investigations of protein–protein interactions of cytochrome P-450 in phospholipid vesicles and liver microsomes
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)34532-0
  contributor:
    fullname: Kawato
– volume: 216
  start-page: 322
  year: 1982
  ident: 10.1016/j.pharmthera.2011.11.009_bb0285
  article-title: Rotational diffusion of cytochrome P-450 in the microsomal membrane-evidence for a clusterlike organization from saturation transfer electron paramagnetic resonance spectroscopy
  publication-title: Arch Biochem Biophys
  doi: 10.1016/0003-9861(82)90217-X
  contributor:
    fullname: Schwarz
– volume: 45
  start-page: 15807
  year: 2006
  ident: 10.1016/j.pharmthera.2011.11.009_bb0155
  article-title: Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions
  publication-title: Biochemistry
  doi: 10.1021/bi061803n
  contributor:
    fullname: Kelley
– volume: 5
  start-page: 6
  year: 2011
  ident: 10.1016/j.pharmthera.2011.11.009_bb0260
  article-title: Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes
  publication-title: Drug Metab Lett
  doi: 10.2174/187231211794455253
  contributor:
    fullname: Reed
– volume: 34
  start-page: 10113
  year: 1995
  ident: 10.1016/j.pharmthera.2011.11.009_bb0370
  article-title: Dynamic interactions of rabbit liver cytochromes P450IA2 and P450IIB4 with cytochrome b5 and NADPH–cytochrome P450 reductase in proteoliposomes
  publication-title: Biochemistry
  doi: 10.1021/bi00032a003
  contributor:
    fullname: Yamada
– volume: 150
  start-page: 155
  year: 1985
  ident: 10.1016/j.pharmthera.2011.11.009_bb0050
  article-title: Kinetic studies on reduction of cytochromes P-450 and b5 by dithionite
  publication-title: Eur J Biochem
  doi: 10.1111/j.1432-1033.1985.tb09001.x
  contributor:
    fullname: Davydov
– volume: 76
  start-page: 729
  year: 2005
  ident: 10.1016/j.pharmthera.2011.11.009_bb0130
  article-title: Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis
  publication-title: Am J Hum Genet
  doi: 10.1086/429417
  contributor:
    fullname: Huang
– volume: 270
  start-page: 177
  year: 1990
  ident: 10.1016/j.pharmthera.2011.11.009_bb0215
  article-title: Immobilized cytochrome P-450LM2. Dissociation and reassociation of oligomers
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(90)81261-L
  contributor:
    fullname: Myasoedova
– volume: 49
  start-page: 315
  year: 1980
  ident: 10.1016/j.pharmthera.2011.11.009_bb0355
  article-title: Oxygen activation by cytochrome P-450
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.bi.49.070180.001531
  contributor:
    fullname: White
– volume: 255
  start-page: 27
  year: 1987
  ident: 10.1016/j.pharmthera.2011.11.009_bb0300
  article-title: Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450
  publication-title: Arch Biochem Biophys
  doi: 10.1016/0003-9861(87)90291-8
  contributor:
    fullname: Sonderfan
– volume: 35
  start-page: 4431
  year: 1986
  ident: 10.1016/j.pharmthera.2011.11.009_bb0100
  article-title: Incorporation of cytochrome b5 into rat liver microsomal membranes. Impairment of cytochrome P-450-dependent mixed function oxidase activity
  publication-title: Biochem Pharmacol
  doi: 10.1016/0006-2952(86)90759-8
  contributor:
    fullname: Gibson
– volume: 342
  start-page: 329
  year: 1997
  ident: 10.1016/j.pharmthera.2011.11.009_bb0375
  article-title: Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450–P450 and cytochrome P450–b5 interactions
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.1997.0125
  contributor:
    fullname: Yamazaki
– volume: 257
  start-page: 7030
  year: 1982
  ident: 10.1016/j.pharmthera.2011.11.009_bb0115
  article-title: Rotation of cytochrome P-450. II. Specific interactions of cytochrome P-450 with NADPH–cytochrome P-450 reductase in phospholipid vesicles
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)34533-2
  contributor:
    fullname: Gut
– volume: 395
  start-page: 57
  year: 2001
  ident: 10.1016/j.pharmthera.2011.11.009_bb0290
  article-title: A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.2001.2574
  contributor:
    fullname: Scott
– volume: 259
  start-page: 2390
  year: 1984
  ident: 10.1016/j.pharmthera.2011.11.009_bb0345
  article-title: Effect of a zwitterionic detergent on the state of aggregation and catalytic activity of cytochrome P-450LM2 and NADPH–cytochrome P-450 reductase
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)43364-3
  contributor:
    fullname: Wagner
– volume: 342
  start-page: 82
  year: 1997
  ident: 10.1016/j.pharmthera.2011.11.009_bb0325
  article-title: Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH–cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.1997.9995
  contributor:
    fullname: Tan
– volume: 285
  start-page: 8942
  year: 2010
  ident: 10.1016/j.pharmthera.2011.11.009_bb0265
  article-title: Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.076885
  contributor:
    fullname: Reed
– volume: 500
  start-page: 335
  year: 2001
  ident: 10.1016/j.pharmthera.2011.11.009_bb0060
  article-title: Association of cytochromes P450 1A2 and 2B4: are the interactions between different P450 species involved in the control of the monooxygenase activity and coupling?
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4615-0667-6_53
  contributor:
    fullname: Davydov
– volume: 33
  start-page: 157
  year: 2005
  ident: 10.1016/j.pharmthera.2011.11.009_bb0120
  article-title: Interactions between CYP2C9 and CYP2C19 in reconstituted binary systems influence their catalytic activity: possible rationale for the inability of CYP2C19 to catalyze methoxychlor demethylation in human liver microsomes
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.104.001578
  contributor:
    fullname: Hazai
– volume: 225
  start-page: 398
  year: 1983
  ident: 10.1016/j.pharmthera.2011.11.009_bb0145
  article-title: Comparisons of warfarin metabolism by liver microsomes of rats treated with a series of polybrominated biphenyl congeners and by the component-purified cytochrome P-450 isozymes
  publication-title: Arch Biochem Biophys
  doi: 10.1016/0003-9861(83)90045-0
  contributor:
    fullname: Kaminsky
– volume: 33
  start-page: 2484
  year: 1994
  ident: 10.1016/j.pharmthera.2011.11.009_bb0175
  article-title: Kinetics of CO binding to cytochromes P450 in the endoplasmic reticulum
  publication-title: Biochemistry
  doi: 10.1021/bi00175a017
  contributor:
    fullname: Koley
– volume: 171
  start-page: 175
  year: 1990
  ident: 10.1016/j.pharmthera.2011.11.009_bb0280
  article-title: Membrane topology of microsomal cytochrome P-450: saturation transfer EPR and freeze-fracture electron microscopy studies
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/0006-291X(90)91373-Z
  contributor:
    fullname: Schwarz
– volume: 34
  start-page: 660
  year: 2006
  ident: 10.1016/j.pharmthera.2011.11.009_bb0270
  article-title: An evaluation of methods for the reconstitution of cytochromes P450 and NADPH P450 reductase into lipid vesicles
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.105.006825
  contributor:
    fullname: Reed
– volume: 108
  start-page: 13486
  year: 2011
  ident: 10.1016/j.pharmthera.2011.11.009_bb0365
  article-title: Structural basis for human NADPH–cytochrome P450 oxidoreductase deficiency
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1106632108
  contributor:
    fullname: Xia
– volume: 34
  start-page: 1244
  year: 1995
  ident: 10.1016/j.pharmthera.2011.11.009_bb0030
  article-title: Substrate-dependent competition of different P450 isozymes for limiting NADPH–cytochrome P450 reductase
  publication-title: Biochemistry
  doi: 10.1021/bi00004a018
  contributor:
    fullname: Cawley
– volume: 90
  start-page: 2651
  year: 1993
  ident: 10.1016/j.pharmthera.2011.11.009_bb0230
  article-title: Expression of truncated forms of liver microsomal P450 cytochromes 2B4 and 2E1 in Escherichia coli: influence of NH2-terminal region on localization in cytosol and membranes
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.90.7.2651
  contributor:
    fullname: Pernecky
– volume: 275
  start-page: 2545
  year: 2000
  ident: 10.1016/j.pharmthera.2011.11.009_bb0040
  article-title: Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.4.2545
  contributor:
    fullname: Cosme
– volume: 245
  start-page: 4851
  year: 1970
  ident: 10.1016/j.pharmthera.2011.11.009_bb0305
  article-title: Phosphatidylcholine requirement in the enzymatic reduction of hemoprotein P-450 and in fatty acid, hydrocarbon, and drug hydroxylation
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)62872-8
  contributor:
    fullname: Strobel
– volume: 278
  start-page: 31269
  year: 2003
  ident: 10.1016/j.pharmthera.2011.11.009_bb0320
  article-title: Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M301489200
  contributor:
    fullname: Szczesna-Skorupa
– volume: 243
  start-page: 1331
  year: 1968
  ident: 10.1016/j.pharmthera.2011.11.009_bb0190
  article-title: Role of hemoprotein P-450 in fatty acid omega-hydroxylation in a soluble enzyme system from liver microsomes
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)56992-7
  contributor:
    fullname: Lu
– volume: 195
  start-page: 565
  year: 1979
  ident: 10.1016/j.pharmthera.2011.11.009_bb0090
  article-title: Properties of NADPH–cytochrome P-450 reductase purified from rabbit liver microsomes
  publication-title: Arch Biochem Biophys
  doi: 10.1016/0003-9861(79)90383-7
  contributor:
    fullname: French
– volume: 20
  start-page: 187
  year: 1971
  ident: 10.1016/j.pharmthera.2011.11.009_bb0080
  article-title: Biochemical and genetic factors influencing drug metabolism. Influence of hepatic microsomal mixed function oxidation reactions on cellular metabolic control
  publication-title: Metabolism
  doi: 10.1016/0026-0495(71)90091-6
  contributor:
    fullname: Estabrook
– volume: 18
  start-page: 5442
  year: 1979
  ident: 10.1016/j.pharmthera.2011.11.009_bb0110
  article-title: Hydrodynamic characterization of highly purified and functionally active liver microsomal cytochrome P-450
  publication-title: Biochemistry
  doi: 10.1021/bi00591a029
  contributor:
    fullname: Guengerich
– volume: 37
  start-page: 12852
  year: 1998
  ident: 10.1016/j.pharmthera.2011.11.009_bb0010
  article-title: Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4–1A2 complex with a high affinity for NADPH–cytochrome P450 reductase
  publication-title: Biochemistry
  doi: 10.1021/bi980674a
  contributor:
    fullname: Backes
– volume: 33
  start-page: 1382
  year: 2005
  ident: 10.1016/j.pharmthera.2011.11.009_bb0225
  article-title: Bimolecular fluorescence complementation analysis of cytochrome p450 2c2, 2e1, and NADPH–cytochrome p450 reductase molecular interactions in living cells
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.105.005538
  contributor:
    fullname: Ozalp
– volume: 38
  start-page: 1003
  year: 2010
  ident: 10.1016/j.pharmthera.2011.11.009_bb0315
  article-title: CYP2C9–CYP3A4 protein–protein interactions in a reconstituted expressed enzyme system
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.109.030155
  contributor:
    fullname: Subramanian
– volume: 38
  start-page: 134
  year: 1990
  ident: 10.1016/j.pharmthera.2011.11.009_bb0025
  article-title: Dual role of phospholipid in the reconstitution of cytochrome P-450 LM2-dependent activities
  publication-title: Mol Pharmacol
  contributor:
    fullname: Causey
– volume: 16
  start-page: 311
  year: 2002
  ident: 10.1016/j.pharmthera.2011.11.009_bb0250
  article-title: The roles of cytochrome b5 in cytochrome P450 reactions
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.10052
  contributor:
    fullname: Porter
– volume: 271
  start-page: 27438
  year: 1996
  ident: 10.1016/j.pharmthera.2011.11.009_bb0380
  article-title: Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4 — characterization of a reconstituted cytochrome P450 3A4 NADPH–cytochrome P450 reductase system and studies with apo-cytochrome b5
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.44.27438
  contributor:
    fullname: Yamazaki
– volume: 270
  start-page: 5014
  year: 1995
  ident: 10.1016/j.pharmthera.2011.11.009_bb0165
  article-title: CO binding kinetics of human cytochrome P450 3A4. Specific interaction of substrates with kinetically distinguishable conformers
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.10.5014
  contributor:
    fullname: Koley
– volume: 255
  start-page: 4112
  year: 1980
  ident: 10.1016/j.pharmthera.2011.11.009_bb0095
  article-title: Interactions of cytochrome P-450, NADPH–cytochrome P-450 reductase, phospholipid, and substrate in the reconstituted liver microsomal enzyme system
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)85640-5
  contributor:
    fullname: French
– volume: 435
  start-page: 207
  year: 2005
  ident: 10.1016/j.pharmthera.2011.11.009_bb0295
  article-title: Interactions of mammalian cytochrome P450, NADPH–cytochrome P450 reductase, and cytochrome b(5) enzymes
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2004.12.008
  contributor:
    fullname: Shimada
– volume: 29
  start-page: 1529
  year: 2001
  ident: 10.1016/j.pharmthera.2011.11.009_bb0035
  article-title: Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Cawley
– volume: 44
  start-page: 2632
  year: 2005
  ident: 10.1016/j.pharmthera.2011.11.009_bb0160
  article-title: Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2
  publication-title: Biochemistry
  doi: 10.1021/bi0477900
  contributor:
    fullname: Kelley
– volume: 19
  start-page: 2260
  year: 1980
  ident: 10.1016/j.pharmthera.2011.11.009_bb0020
  article-title: Cross-linking studies of cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase
  publication-title: Biochemistry
  doi: 10.1021/bi00551a041
  contributor:
    fullname: Baskin
– volume: 44
  start-page: 13902
  year: 2005
  ident: 10.1016/j.pharmthera.2011.11.009_bb0045
  article-title: Kinetics of dithionite-dependent reduction of cytochrome P450 3A4: heterogeneity of the enzyme caused by its oligomerization
  publication-title: Biochemistry
  doi: 10.1021/bi0509346
  contributor:
    fullname: Davydov
– volume: 36
  start-page: 228
  year: 2004
  ident: 10.1016/j.pharmthera.2011.11.009_bb0085
  article-title: Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
  publication-title: Nat Genet
  doi: 10.1038/ng1300
  contributor:
    fullname: Flück
– volume: 97
  start-page: 139
  year: 2003
  ident: 10.1016/j.pharmthera.2011.11.009_bb0275
  article-title: The many roles of cytochrome b5
  publication-title: Pharmacol Ther
  doi: 10.1016/S0163-7258(02)00327-3
  contributor:
    fullname: Schenkman
– volume: 599
  start-page: 417
  year: 1980
  ident: 10.1016/j.pharmthera.2011.11.009_bb0135
  article-title: Incorporation of purified components of the rabbit liver microsomal hydroxylase system into phospholipid vesicles
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2736(80)90188-1
  contributor:
    fullname: Ingelman-Sundberg
– volume: 275
  start-page: 235
  year: 1990
  ident: 10.1016/j.pharmthera.2011.11.009_bb0210
  article-title: Cytochrome P-450LM2 oligomers in proteoliposomes
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(90)81479-8
  contributor:
    fullname: Myasoedova
– volume: 251
  start-page: 4010
  year: 1976
  ident: 10.1016/j.pharmthera.2011.11.009_bb0240
  article-title: Temperature dependence of cytochrome P-450 reduction. A model for NADPH–cytochrome P-450 reductase:cytochrome P-450 interaction
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)33349-5
  contributor:
    fullname: Peterson
– volume: 188
  start-page: 216
  year: 1992
  ident: 10.1016/j.pharmthera.2011.11.009_bb0055
  article-title: High pressure induced inactivation of ferrous cytochrome P-450 LM2 (IIB4) CO complex: evidence for the presence of two conformers in the oligomer
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/0006-291X(92)92372-5
  contributor:
    fullname: Davydov
SSID ssj0004402
Score 2.3760655
SecondaryResourceType review_article
Snippet Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s...
SourceID pubmedcentral
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 299
SubjectTerms Animals
Binding, Competitive
Cytochrome P-450 Enzyme System - chemistry
Cytochrome P-450 Enzyme System - metabolism
Humans
NADPH-Ferrihemoprotein Reductase - metabolism
Title Formation of P450 · P450 complexes and their effect on P450 function
URI https://www.ncbi.nlm.nih.gov/pubmed/22155419
https://pubmed.ncbi.nlm.nih.gov/PMC3272114
Volume 133
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZ4LCyIN-UlD7QLpGodtw4jICqEACFUJLbIjs8CJEoFRQIG_hY7v4yznacoErAkUWK7yX2Xy_n63ZmQbQZa7xndCRQTOuCS8yBiMglsiAG9W-hExuYOn513j6_4yXXnuljmzmWXjFQzeRubV_IfVPEc4mqzZP-AbD4onsBjxBe3iDBuf4VxL8s8dEw23mnt1A9Z_UD4Y8cWhxd4yliSt48pfcP-Q-Ca2K9ajkzqol4Uxaw9m6aUouVCtD7HsBRCuAQfMXWM2xIDUaKF8CQ--Yq-7Gk5wmCpGhnFqgneKkbCkqrckoOF2fQFLFL9CMtG0C959M04-zjBXXNon8Pduy-haquotipdUMzDewcaY9bhSa1qtTB2dmmSTDO0Mta8Nd8Lfg8vqFue0Df-Z2016HSgimuS-yNVrmzJ-ejPkdl01kD3vQrMkwkYLJBGitTrLu2XINqlDVrGcJEc5XpCHwy1wNPPD7_PdYSijlCnI9TrCMXWrkmmI0vkqnfUPzwO0uUzggQfZhQkOJVkMuKqqyOI0FhrqYXAjxvjIFpGgBI61CHXewkzXWWkQd9YG4lzatUyCsJlMjV4GMAqChGA67ZI2kkX32F8fdGxAylVCAL7g6qRdia5eOirpMQZffAuLgQfW8HjpDNGwdfIipds3iPDoUZEReZ5A1sKvXplcHvjSqKHzEYy-NqPY66TmUK1N8jU6PEZNtGdHKktpzZfJUZzYQ
link.rule.ids 230,315,783,787,888,27936,27937
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Formation+of+P450+%C2%B7+P450+complexes+and+their+effect+on+P450+function&rft.jtitle=Pharmacology+%26+therapeutics+%28Oxford%29&rft.au=Reed%2C+James+R&rft.au=Backes%2C+Wayne+L&rft.date=2012-03-01&rft.eissn=1879-016X&rft.volume=133&rft.issue=3&rft.spage=299&rft_id=info:doi/10.1016%2Fj.pharmthera.2011.11.009&rft_id=info%3Apmid%2F22155419&rft.externalDocID=22155419
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-7258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-7258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-7258&client=summon